LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Stoelzle – 15th May 2025

Applying Advanced Powder Testing to Tackle the Toughest Formulation Challenges

The application of high throughput screening techniques and computational chemistry has resulted in a marked shift in drug candidates with identified therapeutic potential, increasing the prevalence of BCS Class II and IV compounds. Faced with a growing need to effectively develop these drugs, formulators are becoming increasingly reliant on more complex and sophisticated strategies. The intensifying requirement to effectively formulate Class II and IV drugs increases the need to optimise analytical strategies. Jamie Clayton at Freeman Technology considers the value of powder rheometry within this context, focusing on its ability to support innovative product development.

Scott Pharma – 25.03.2025
Bespak – 21.05.2025
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Nipro – 09.06.2025
L.B. Bohle – 08.04.2025
Drug Discovery 2025, ELRIG – 04.07.2025